Publication | Closed Access

Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients

Consecutive PatientsSurgical OncologySecond Line TreatmentUrologyGenitourinary CancerMedicineTargeted TherapiesCancer TreatmentOncologyRadiation OncologyKidney Research